Recent evidence suggests mesenchymal stem cells (MSCs) can downmodulate bleomycin-induced lung injury, and umbilical cord blood (UCB) is a promising source for human MSCs. This study examined whether intratracheal or intraperitoneal transplantation of human UCB-derived MSCs can attenuate hyperoxia-induced lung injury in immunocompetent newborn rats. Wild-type Sprague-Dawley rats were randomly exposed to 95% oxygen or air from birth. In the transplantation groups, a single dose of PKH26-labeled human UCBderived MSCs was administered either intratracheally (2 × 10 6 cells) or intraperitoneally (5 × 10 5 cells) at postnatal day (P) 5. At P14, the harvested lungs were examined for morphometric analyses of alveolarization and TUNEL staining, as well as the myeoloperoxidase activity, the level of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and transforming growth factor (TGF)-β mRNA, α-smooth muscle actin (SMA) protein, and collagen levels. Differentiation of MSCs to the respiratory epithelium was also evaluated both in vitro before transplantation and in vivo after transplantation. Despite one fourth dosage of MSCs, significantly more PKH26-labeled donor cells were recovered with intratracheal administration than with intraperitoneal administration both during normoxia and hyperoxia. The hyperoxia-induced increase in the number of TUNELpositive cells, myeloperoixdase activity, and the level of IL-6 mRNA were significantly attenuated with both intratracheal and intraperitoneal MSCs transplantation. However, the hyperoxia-induced impaired alveolarization and increased the level of TNF-α and TGF-β mRNA, α-SMA protein, and collagen were significantly attenuated only with intratracheal MSCs transplantation. MSCs differentiated into respiratory epithelium in vitro and a few PKH26-positive donor cells were colocalized with pro surfactant protein C in the damaged lungs. In conclusion, intratracheal transplantation of human UCB-derived MSCs is more effective than intraperitoneal transplantation in attenuating the hyperoxia-induced lung injury in neonatal rats.
INTRODUCTION
development of hyperoxic neonatal lung injury and BPD (42) . Recently, the exogenous administration of bone mar-Bronchopulmonary dysplasia (BPD) is a chronic pulmonary disease that usually occurs in premature infants row (BM)-derived mesenchymal stem cells (MSCs) significantly attenuated the bleomycin-induced lung injury receiving prolonged ventilatory support and oxygen supplementation. It is also an important cause of mortality by downmodulating the inflammatory responses and ameliorating their fibrotic effects (33) . In addition, the trans-and long-term respiratory morbidity with few effective treatments (3,6). The histopathological characteristics of planted cells assumed the lung parenchymal cell phenotypes (34). The anti-inflammatory effect of MSCs has BPD include impaired alveolarization and interstitial fibrosis (30). Prolonged exposure of neonatal rodents to also been reported in various animal models such as an ischemia/reperfusion injury of the kidney (36) and acute hyperoxia results in decreased alveolarization and increased lung fibrosis, which simulates the histopathol-myocarditis (31). Overall, MSCs transplantation might be a new therapeutic modality for the treatment of hy-ogy of human BPD (11, 43) . Inflammation is believed to play a key role in the lung injury process leading to the peroxic neonatal lung injury or BPD.
Among the various sources, including BM, umbilical vine serum. These cells were isolated from human newborn foreskin fibroblasts. cord blood (UCB), and adipose tissue (39) , UCB is considered a promising source for human MSCs on account
In Vitro Differentiation to Respiratory Epithelium of its easy availability. Furthermore, human UCB-derived MSCs have been successfully isolated, cultivated, and
As reported previously (4), when the culture of cells (MSCs and HS68) reached 70% confluence, culture me-shown to differentiate into various cell types such as osteoblasts, chondrocytes, adipocytes, stromal cells, skeletal dium was replaced completely with small airway growth medium (SAGM; Cambrex BioScience, Walkersville, cells, neural cells, and endothelial cells both in vivo and vitro (17, 21, 25, 45) , and even to lung-specific cells in MD, USA) to induce a respiratory epithelial differentiation. The cells were visualized by optical microscopy vitro (4). However, it is not known if human UCB-derived MSCs can differentiate into lung specific cell types in (Eclipse TE2000-U, Nikon, Tokyo, Japan) throughout the culture period. vivo, and whether these cells are suitable exogenous stem cell sources in lung injuries of experimental or Five days after the induction of the differentiation, the cells were harvested and lysed to isolate RNA. Re-clinical settings.
The optimal route for stem cell transplantation is an-verse transcriptase polymerase chain reaction (RT-PCR) was performed according to previously published tech-other issue that needs to be determined before it can have clinical applications. In contrast to a normal lung, niques (45) . The total RNA was isolated from undifferentiated and differentiated cells using Trizol reagent an injured lung produces soluble factors that cause MSCs to proliferate and migrate toward an injured lung (Invitrogen, La Jolla, CA, USA) according to the manufacturer's instruction. Complementary DNA (cDNA) was (34). Moreover, systemically administered MSCs have been shown to localize to an injured lung (33) . However, synthesized from 2.5 µg total RNA using SuperScript II reverse transcriptase (Invitrogen), oligo-dT primer, 5× it is unclear if the local, intratracheal administration of MSCs is comparable or better than systemic transplanta-first-strand buffer, dNTP, dTT, and RNaseOUT ribonuclease inhibitor. Two sequential PCR reactions were tion.
Therefore, the therapeutic efficacy of exogenous hu-performed to test for the presence of a surfactant protein C (SP-C) gene. The glyceraldehyde-3-phosphate dehy-man UCB-derived MSCs transplantation, the optimal route of its administration, and its possible protective drogenase (GAPDH) gene was tested as a control for the quality and quantity of RNA. One microliter of mechanism were investigated in a hyperoxic neonatal lung injury. In particular, this study examined whether cDNA (200 ng/µl) was used in the first PCR amplification using the following conditions and sequence-spe-intratracheal or intraperitoneal human UCB-derived MSCs transplantation could attenuate an hyperoxia-induced lung cific primers: 5 min hot start at 95°C, 30 cycles of 95°C for 30 s, 57°C for 30 s, 72°C for 30 s, and a final exten-injury in immunocompetent newborn rat pups and, if so, whether its protective effect is associated with anti-sion for 5 min at 72°C; 5′-AAAGAGGTCCTGATGGA GAGC-3′ and 5′-TAGATGTAGTAGAGCGGCACCT-inflammatory responses and/or by regeneration through their differentiation into lung specific cells.
3′, which amplify a product of 456 base pairs. One microliter of the product from the first reaction was used as a template for the second PCR amplification step, MATERIALS AND METHODS using the same cycling conditions outlined above but Cell Preparation with the sequence-specific primers, 5′-AACGCCTTCT TATCGTGGTG-3′ and 5′-GTGAGAGCCTCAAGAC The MSCs were isolated and cultivated from human UCB, as previously reported (18, 43) . The cells ex-TGG-3′, which amplify a product of 313 base pairs. The PCR products were resolved by agarose gel electropho-pressed CD105 (99.6%) and CD73 (96.3%), but not CD34 (0.1%), CD45 (0.2%), and CD14 (0.1%). They resis and visualized by ethidium bromide staining. For the immunostaining procedure, the cells in were positive for HLA-AB but generally not for HLA-DR. The cells also expressed the pluripotency markers SAGM by 0 and 5 days were fixed in 4% paraformaldehyde for 10 min, and incubated overnight at 4°C with such as Oct 4 and SSEA-4. As previously reported (18, 24, 45) , the human UCB-derived MSCs differentiated pro SP-C (Chemicon, Temecula, CA, USA). The secondary Cy-3 goat anti-rabbit antibody (Jackson Immuno-into various cell types such as osteoblasts, chondrocytes, and adipocytes with in vitro induction by the specific Research, West Grove, PA, USA) was incubated with the cells for 30 min at room temperature. Nuclear coun-osteogenic, chondrogenic, and adipogenic differentiation stimulus, and this differentiation ability of MSCs was terstaining was performed using 4′,6-diamidino-2-phenylindole (DAPI), and the images were captured on a Ni-maintained up to the 10th passage. Human fibroblast (HS68; ATCC, CRL-1635, Rockville, MD, USA) were kon TE 2000-U using a Nikon digital camera. For flow cytometric analysis of pro SP-C expression, undifferen-cultured in α-MEM supplemented with 10% fetal bo-tiated and differentiated cells by day 0 and day 5 in tation group (HF, n = 9), and hyperoxia with intratracheal MSCs transplantation group (HT2, n = 9). SAGM, respectively, were suspended in Cytofix/Cytoperm fixation/permeabilization solution (Becton-Dickin-Transplantation of Donor Cells son, San Jose, CA, USA), and were washed with Perm/ Wash buffer (Becton-Dickinson). After blocking with
The human UCB-derived MSCs from the 5th passage from a single donor were labeled using a PKH26GL Red 10% goat serum in Perm/Wash buffer for 45 min on ice, the cells were incubated with rabbit anti-human pro SP-Fluorescent Cell Membrane Labeling Kit (Sigma-Aldrich, St. Louis, MO, USA) for transplantation according to C antibody (at 1:200 dilution) (Chemicon) in the blocking solution for 45 min on ice. The cells were resus-the manufacturer's protocol. The donor cells were transplanted at P5. For the donor cell transplantation, 2 × 10 6 pended in Perm/Wash buffer after incubation with goat anti-rabbit IgG conjugated with fluorescein isothiocya-MSCs in 0.2 ml phosphate-buffered saline (PBS, pH 7.4) were administered intraperitoneally (NP and HP) nate (FITC) (at 1:200 dilution) (Jackson ImmunoResearch) for 45 min on ice, and analyzed by flow cytometer (Bec-and 5 × 10 5 cells (MSCs or fiborblasts) in 0.05 ml PBS were administered intratracheally (NT, HT, HT2, and ton-Dickinson).
HF). As we expected better delivery of donor cells with Animal Model direct local administration than with indirect systemic transplantation, one fourth dosage of cells compared to All the procedures and experimental protocols were reviewed and approved by the Institutional Animal Care that of systemic intraperitoneal administration was given for local intratracheal MSCs transplantation. and Use Committee of Samsung Biomedical Research Institute. This study also followed the institutional and For intratracheal transplantation, the rats were anesthetized with an intraperitoneal injection of a ketamine National Institutes of Health guidelines for laboratory animal care. Timed-pregnant Sprague-Dawley rats were and xylazine mixture (45 mg/kg and 8 mg/kg, respectively), and restrained on a board at a fixed angle. The purchased from Orient Co. (Seoul, Korea), and housed in individual cages with free access to water and labora-MSCs or fibroblasts were administered into the trachea through a 26-gauge needle syringe. After the procedure, tory chow. The rats were delivered spontaneously. The experiment began within 10 h after birth and was contin-the animals were allowed to recover from the anesthesia, and were returned to their dam. There was no mortality ued until postnatal day (P) 14. One hundred fifty-eight rat pups were divided into the following six groups: nor-associated with the transplantation procedure. moxia control group (NC, n = 10); normoxia with intra-Tissue Preparation peritoneal human UCB-derived MSCs transplantation group (NP, n = 14); normoxia with intratracheal MSCs All tissue preparation procedures for the various analyses were performed only in the surviving animals at transplantation group (NT, n = 14); hyperoxia control group (HC, n = 40); hyperoxia with intraperitoneal P14. The animals were anesthetized with sodium pentobarbital (100 mg/kg). The lungs were exposed by a tho-MSCs transplantation group (HP, n = 40); and hyperoxia with intratracheal MSCs transplantation group (HT, n = racotomy and transcardiac perfusion with ice-cold PBS. The lungs were fixed by the tracheal instillation of a 4% 40). The rat pups from the normoxia groups were kept in a standard cage with a nursing rat at room air, and formaldehyde solution at a constant inflation pressure of 25 cm H 2 O (n = 6, 4, 8, 8, 11, 4, 13, 6, 10, and 7 in the the pups from the hyperoxia groups were kept in a standard cage with a nursing rat within a 50-L Plexiglas NC, NC2, NP, NT, HC, HC2, HP, HF, HT, and HT2 groups, respectively). The trachea was then ligated and chamber in which hyperoxic condition (95% oxygen concentration) was maintained throughout the experi-the lungs were removed and immersed in the same fixative overnight at room temperature. The fixed right ment. The humidity was maintained at 50%, and the environmental temperature was maintained at 24°C. The lungs were embedded in paraffin, and the left lungs were embedded in an optimal cutting temperature (OCT) nursing mother rats were rotated daily between litters in the normoxia and hyperoxia groups to avoid oxygen compound (SAKURA 4583, Sakura, Torrance, CA, USA). Blocks of the OCT compound were sectioned at 10 µm toxicity.
We also performed an additional set of experiments on a cryostat (Shandon Cryotome, Thermo Electron Co., Waltham, MA, USA) and stored in a deep freezer until comparing the effects of intratracheal administration of fibroblasts and UCB-derived MSCs to verify that the analyzed by immunohistochemistry. Transverse serial sections (4 µm thick) were taken from the paraffin beneficial effects described in this study are specific to UCB-derived MSCs. Animals for this separate study blocks of the right middle and lower lobe for morphometric and some immunohistochemistry analyses. For were divided into four groups: normoxia control group (NC2, n = 4), hyperoxia control group (HC2, n = 6), hy-the scanning electron microscopy (SEM) examination, paraffin blocks (6 × 6 × 3 mm) of the right upper lobe peroxia with intratracheal fibroblasts (HS68) transplan-of the lung (n = 3 in each group) were dehydrated with kon, Tokyo, Japan) using a filter to detect the PKH26 red fluorescence. The PKH26 red fluorescence was ethanol and isoamyl acetate, further processed using the critical point method, coated with gold (100 A), and ex-counted manually and averaged per high-power field (HPF) in a single animal. Two random sections per ani-amined with a examined by SEM (JSM-5300, Jeol, Tokyo, Japan). Particular attention was paid to the mal were evaluated in a blinded manner. expansion pattern of the terminal airspaces and to the TUNEL Staining surface of conducting airways.
The lungs were excised, frozen in the liquid nitrogen, The immunofluorescent terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end homogenized, and the myeloperoxidase activity, αsmooth muscle actin (SMA) protein, collagen levels as labeling (TUNEL) technique (kit S7110 ApopTag, Chemicon, Temecula, CA, USA) was used to determine well as RT-PCR of the tissue cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, and trans-the level of apoptosis in the 4-µm-thick paraffin sections of the lung according to the manufacturer's protocol. forming growth factor (TGF)-β were measured (n = 4, 6, 6, 6, 8, and 6 in the NC, NP, NT, HC, HP, and HT
The slides were mounted with a vector shield mounting solution containing DAPI (H-1200, Vector) and visual-group, respectively).
ized by fluorescent microscopy (Nikon E600, Nikon) at Morphometric Analysis 20× objective. The number of TUNEL-positive cells was determined in 10 nonoverlapping random fields per Sections (4 µm thick) from the paraffin blocks were stained with hematoxylin and eosin. Two sections per animal in a blinded manner. rat were chosen randomly, and three microscopic ran-Myeloperoxidase Activity (MPO) dom fields of the distal lung were analyzed in each section. The level of alveolarization was determined by
The MPO activity in the homogenized lung tissues, which is an indicator of neutrophil accumulation or ac-measuring the mean linear intercept (MLI) and mean alveolar volume. Briefly, images of each field were cap-tivity, was determined using a modification of the method reported by Gray et al. (14) . One unit of MPO tured using a pixera 600CL-CU digital camera (Pixera Corporation, Los Gatos, CA, USA) through an Olympus activity was defined as the quantity of enzyme degrading 1 µmol of peroxide/min. BX50 microscope (Olympus, Tokyo, Japan) at 10× or 20× objectives and saved as JPEG files. The mean inter-Semiquantitative RT-PCR alveolar distance was measured as the mean linear intercept (MLI), by dividing the total length of the lines The total RNA in the sample was extracted using a RNA Trizol kit (Invitrogen Corporation, Carlsbad, CA, drawn across the lung section by the number of intercepts encountered, as described by Cooney and Thurl-USA) according to the manufacturer's protocol. One microgram of RNA was used to produce the cDNA using beck (10). The mean alveolar volume was calculated using the method reported by Snyder et al. (8, 38) . Briefly, a Protoscript II RT-PCR kit (New England Biolabs, Ipswich, MA, USA). The PCR primers for the rat TNF-a grid containing equally spaced crosses was placed on a uniformly enlarged photomicrograph of each lung α, IL-6, and TGF-β, and GAPDH were designed with Primer3 (Whitehead Institude, Cambridge, MA, USA), field. The diameters (R) of the alveoli containing a cross were measured along the horizontal axis of the cross. and synthesized from Bioneer Inc. (Bioneer, Daejeon, Korea). The following primers sequences were used: The cube of the alveolar diameter times π and divided by 3 (R 3 π/3) was used to estimate the mean alveolar vol-TNF-α (sense 5′-TACTGAACTTCGGGGTGATCGG TCC-3′, antisense 5′-CAGCCTTGTCCCTTGAAGA ume. The analysis of each section was carried out in a blinded manner. GAACC-3′); TGF-β (sense 5′-CAACTGTGGAGCAA CACGTAGA-3′, antisense 5′-CAACCCAGGTCCTTC Quantification of the PKH26-Positive Cells CTAAAGT-3′; IL-6 (sense 5′-CACCAGGAACGAAA GTCAACTC-3′, antisense 5′-GGAAGCATCCATCAT Cryosections (10 µm thick) were mounted with a Vector shield mounting solution containing DAPI (H-TTCTTTG-3′); GAPDH (sense 5′-CTCTACCCACGG CAAGTTCAA-3′, antisense 5′-GGGATGACCTTGCC 1200, Vector, Burlingame, CA, USA). The cell counts for the transplanted or donor-derived cells were mea-CACAGC-3′).
For each reaction, 1 µl of cDNA was placed in a 19-sured using PKH26 red fluorescence, as described above after combining the 20× objective images of the DAPI-µl reaction mixture PCR Master Mix (Bioneer), and 0.5 µM of each primer (Bioneer). All amplification reac-stained nuclei signals. Five fields per section were selected randomly, focused, and counted with the naked tions were carried out in a T1 thermocycler (Biometra, Goettingen, Niedersachsen, Germany). The cycle profile eye under a fluorescence microscope (Nikon E600, Ni-involved 33 cycles of the following: 60 s at 95°C, 60 s Immunohistochemistry at X°C, where X is the annealing temperature for each SMA expression in the lung tissue was evaluated pair of cytokine primers (60°C for TNF-α, 56°C for from deparaffinized 4-µm-thick lung sections using the TGF-β, 55°C for IL-6, and 57°C for GAPDH), and 60 s avidin-biotin-peroxidase method. After quenching of the at 68°C. The PCR products were separated by 1.2% endogenous peroxidase activity with 3% H 2 O 2 for 20 agarose gel electrophoresis, visualized by ethidium bromin, the sections were incubated with the mouse antimide, and scanned using a Gel Doc 2000 analyzer (Bio-SMA antibody (1:200 DAKO, Carpinteria, CA, USA). Rad, Hercules, CA, USA). The expression level of each
The immune complexes were visualized using the relegene was semiquantified by densitometric analysis using vant peroxidase-coupled secondary antibody provided in Quantity One software (Bio-Rad). The relative expresthe LSAB TM 2 Kit (DAKO). sion levels were estimated from the density ratio of the Immunofluorescence histochemistry for donor cell cytokines to GAPDH (control).
localization was performed on the 10-µm-thick cryostat sections. The following primary antibody dilutions were Western Blot for α-SMA used: 1:500 for pro SP-C (rabbit polyclonal; Sterologi-The frozen lung samples were homogenized in a cold cals Co. Lake Placid, NY, USA), 1:100 for aquaporin 5 buffer (50 mM Tris-HCl, pH 7.4), EDTA (1 mM), (rabbit polyclonal; Chemicon,), 1:50 for vimentin (mouse EGTA (1 mM), PMSF (1 mom), KCl (42 mM), and monoclonal; Chemicon), 1:100 for SMA (Spring Biosci-MgCl 2 (5 mM). The samples were centrifuged at 7000 ence, Fremont, CA, USA), and 1:100 for monocyte/macrpm for 20 min at 4°C to remove the cellular debris. The rophages (CD68) (ED-1, mouse monoclonal, Chemiprotein content in the supernatant was determined using con). Alexa Fluor 488 goat anti-mouse IgG (1:500, the Bradford method, with bovine serum albumin Molecular Probes, Eugene, OR, USA) and Cascade Blue (Sigma-Aldrich) as the standard. Western blot analysis goat anti-mouse IgG (1:200, Molecular Probes) were was carried out using the standard method and enhanced used as the secondary antibodies for immunofluoreschemiluminescence detection reagents (ECL-kit, Amercence. The frozen lung sections were fixed with 4% sham Pharmacia Biotech, Piscataway, NJ, USA). Monoparaformaldehyde for 30 min and treated with 1% boclonal α-SMA (1:500, Sigma-Aldrich) and anti-α-tubulin vine serum albumin containing 0.1% Triton for a further (1:1000, Calbiochem, Darmstadt, Hessen, Germany) an-30 min. The sections were then blocked with 3% normal tibodies, and the anti-mouse IgG horseradish peroxidase goat serum containing 0.1% Triton X-100 in PBS for 1 (HRP) antibody (1:1,000, Dako, Carpinteria, CA, USA) h at room temperature. The sections were incubated with were used. The α-SMA expression levels were estithe primary antibodies overnight at 4°C, rinsed in PBS, mated from the density ratio of α-tubulin. Densitometry and incubated with the secondary antibodies in a blockwas performed using Image J (NIH, Bethesda, MA, USA).
ing solution for 1 h. The confocal microscopy examination was carried out using a Biorad Radiance 2100 (Bio-
Measurement of Collagen
Rad) with a krypton/argon laser and the images were The lung collagen level was determined from the togenerated using lasershop 2000 software (Bio-Rad,). tal soluble collagen using a Sircol collagen assay kit (Bio-
The cells were considered to be double-labeled if colabcolor Ltd., Newton Abbey, UK) according to the manueling with the relevant morphology had occurred when facturer's instructions. The lungs were homogenized in viewed in the x-z cross-sections, which was produced 5 ml of a 0.5 M acetic acid solution containing 1 mg by an orthogonal reconstruction from the z-series (zpepsin (Sigma Chemical Co., St. Louis, MO, USA) per step, 1 or 2 µm) taken with 60× or 80× objectives. The 10 mg tissue. Each sample was incubated for 24 h at images were pseudocolored using image processing 4°C with constant shaking. After centrifugation, 100 µl software (Adobe Photoshop, San Jose, CA, USA). of each supernatant was assayed. Sircol dye reagent (1 Statistical Analysis ml) that specifically binds to collagen was then added to each sample and mixed for 30 min. After centrifugation,
The data are expressed as the mean ± SEM. Survival curve comparisons were performed using Kaplan-Meier the pellet was suspended in 1 ml of an alkali reagent (0.5 M NaOH) included in the kit, and the OD was eval-analysis followed by a log rank test. For continuous variables with a normal distribution, multiple group uated with a spectrophotometer at a wavelength of 540 nm.
comparisons were performed using t-test with a Bonferroni correction. Variables not showing a normal distri-The values in the test samples were compared with those obtained with the standard collagen solutions pro-bution, such as the cell counts, were analyzed using a Wilcoxon Rank test with Bonferroni correction for the vided by the manufacturer, which were used to construct a standard curve. multigroup comparison. All data were analyzed using the SAS software program, SAS Enterprise Guide 3.0 attenuation of the hyperoxia-induced morphometric abnormalities with the intratracheal MSCs transplantation (SAS Institute Inc., Cary, NC, USA). Values of p < 0.05 were considered significant.
(HT2; p < 0.01 vs. HC2, p < 0.01 vs. HF) was not observed with the intratracheal fibroblast transplantation.
RESULTS
These findings indicate that these beneficial effects are In Vitro Differentiation of MSCs specific to UCB-derived MSCs (Fig. 3) .
to Respiratory Epithelium
The deposition of PKH26 red fluorescence-positive donor cells was observed only in the MSCs transplanta-While the undifferentiated cells maintained a fibrotion groups, but not in NC and HC (Fig. 4) . The number blast-like morphology (Fig. 1A: a) , after 5 days of inof donor cells identified per lung field was significantly duction in SAGM, the human UCB-derived MSCs diflarger in the intratracheal MSCs transplantation groups ferentiated and showed an epitheloid morphology ( Fig. (NT and HT) (p < 0.05) than in the intraperitoneal trans-1A: b). In contrast, HS68 showed no morphological plantation groups (NP and HP). However, there were changes after 5 days of induction in SAGM ( Fig. 1A : c, no significant differences in the donor cells between the d). The presence of SP-C, a specific marker of type II hyperoxia and normoxia groups (NP vs. HP, NT vs. HT). pneumocytes, was confirmed to be in the differentiated MSCs by both RT-PCR ( Fig. 1B: a) and immunofluores-TUNEL Staining cence staining ( Fig. 1C: b , c) at day 5, but not in the The number of TUNEL-positive cells in the lung of HS68 ( Fig. 1B: b, 1C : e, f). Specific pro SP-C protein the P14 rats per high-power field was significantly expression examined by flow cytometry was observed higher in HC (p < 0.001) than in the normoxia groups only in the differentiated MSCs ( Fig. 1D: a) , but not in (Fig. 5 ). This hyperoxia-induced increase in the number the HS68 fibroblasts ( Fig. 1D: b) .
of TUNEL-positive cells was significantly attenuated Histological Evaluation by Optical Microscopy after both intraperitoneal and intratracheal MSCs transand SEM plantation (p < 0.05 vs. HC). Although the hyperoxia-induced decrease in the sur-Myeloperoxidase Activity vival rate was not significantly improved (43% in HC, 53% in HP, 40% in HT, and 100% in NC, NP, and NT),
In HC, the MPO activity was significantly higher (p < 0.001) than in the normoxia groups (NC, NT, and NP) intratracheal MSCs transplantation significantly attenuated the hyperoxia-induced histopathological lung injur- (Fig. 6A ). This hyperoxia-induced increase in MPO activity was significantly attenuated in both HT (p < 0.001 ies in the surviving rat pups at P14. Figure 2 presents typical photomicrographs showing the histopathological vs. HC) and HP (p < 0.01 vs. HC), and this attenuation was more significant in HT (p < 0.01) than in HP. differences observed by optical microscopy ( Fig. 2A) and SEM (Fig. 2B ) in each experimental group. Both mRNA Expression of TNF-α, IL-6, and TGF-β the optical microscopy and SEM examination revealed uniform and small alveoli in the normoxia control group
The mRNA levels of TNF-α, IL-6, and TGF-β, which were analyzed by semiquantitative RT-PCR, were (Fig 2A, B in NC) , and the human UCB-derived MSCs transplantation to the normoxic newborn rats did not significantly higher in HC (p < 0.001) than in the normoxia groups (NC, NT, and NP) (Fig. 6B) . The in-cause any significant histological abnormalities in the P14 lungs ( Fig. 2A, B in NP, NT). In HC, impaired creased IL-6 levels observed in HC were significantly attenuated in both HT (p < 0.01 vs. HC) and HP (p < alveolar growth, as evidenced by the fewer and larger alveoli ( Fig. 2A in HC) , focal airspace enlargement, a 0.05 vs. HC), and this attenuation was more profound in HT (p < 0.05) than in HP. The hyperoxia-induced in-heterogeneous alveolar size, and more corrugated alveolar surface of the lung (Fig. 2B in HC) were observed. crease in TNF-α and TGF-β (p < 0.001 vs. NC) was significantly attenuated only in HT (p < 0.01 vs. HC, After MSCs transplantation, the hyperoxia-induced morphological changes and impaired alveolar growth were p < 0.05 vs. HP), but not in HP. attenuated, particularly in HT ( Fig. 2A, B in HT) when α-SMA and Collagen compared to HP ( Fig. 2A, B in HP) .
In morphometric analyses, the mean linear intercept The α-SMA and collagen levels were measured to assess the degree of lung fibrosis. The level of the α-(MLI) and mean alveolar volume, indicating the size and volume of the alveoli, respectively, were significantly SMA protein was significantly higher in HC (p < 0.001) than in the normoxia groups (NC, NT, and NP). This higher in HC (p < 0.01) than those in the normoxia groups. These hyperoxia-induced abnormalities in morphometry hyperoxia-induced increase in α-SMA was significantly attenuated only in HT (p < 0.01 vs. HC, p < 0.01 vs. were significantly attenuated in HT (p < 0.05 vs. HC), but not in HP (Fig. 2C) . Furthermore, the significant HP), but not in HP (Fig. 7A) . NC, normoxic control rats; NP, normoxic rats with intraperitoneal human UCB-derived MSCs transplantation; NT, normoxic rats with intratracheal MSCs transplantation; HC, 95% hyperoxia-exposed control rats; HP, hyperoxia-exposed rats with intraperitoneal MSCs transplantation; HT, hyperoxia-exposed rats with intratracheal MSCs transplantation.
The lung collagen levels at P14 were significantly markers was examined by immunofluorescence staining. A few definite colabelings of PKH26 with pro SP-C, higher in HC (p < 0.001) than in the normoxia groups (NC, NP, and NT). This hyperoxia-induced increase in a type II alveolar epithelial cell-specific marker, were observed (Fig. 8A ). There was no colocalization of ED-the lung collagen levels was significantly attenuated only in HT (p < 0.01 vs. HC, p < 0.01 vs. HP), but not 1, a specific marker of alveolar macrophages, with this double labeling with PHK26 and pro SP-C, thus exclud-in HP (Fig. 7B) .
ing the possibility that this colocalization was an inci-Colabeling of Localized Donor Cells In Vivo dental finding due to phagocytosis by the alveolar macrophages, rather than a true in vivo differentiation ( and mean alveolar volume (lower) between P14 rat lungs exposed in hyperoxia with intratracheal fibroblast transplantation and those with intratracheal MSCs transplantation. Data are mean ± SEM; n = 4, 4, 6, and 7 in NC2, HC2, HF, and HT2. *p < 0.01 versus NC2; **p < 0.001 versus NC2; #p < 0.01 versus HC2; †p < 0.01 versus HF. NC2, normoxic control rats; HC2, hyperoxic control rats; HF, hyperoxic rats with intratracheal fibroblast transplantation; HT2, hyperoxic rats with intratracheal MSCs transplantation. lial cell-specific marker, vimentin, an indicator of fibro-also confirmed that the protective effects observed in the present study are specific to UCB-derived MSCs, but blast, or α-SMA, an indicator of myofibroblasts was not observed in the present study. not to fibroblasts. The optimal route for stem cell transplantation in a DISCUSSION lung injury has not been determined yet. In a bleomycininduced lung injury, some soluble factors are produced In this study, although the survival rate was not significantly improved, the transplantation of human UCB-from injured lungs but not from normal lungs, which allows systemically administered MSCs to be homed to derived MSCs to the wild-type newborn rat pups significantly attenuated the hyperoxia-induced lung injury in an injured lung (33, 34) . In the present study, the MSCs were given intraperitoneally instead of by the intrave-the surviving animals. This protective effect was associated and probably mediated by the downmodulation of nous or intra-arterial route for systemic cell administration due to the small size of the newborn P5 rat pups the pulmonary inflammatory and the ensuing fibrotic responses. The engraftment of donor cells and attenuation weighing only 7-9 g. This intraperitoneal route was also used in the earlier studies in the newborn mice (13, 44) , of the hyperoxia-induced lung injury were more prominent with the intratracheal administration of MSCs than and P7 rats (29) , and the intraperitoneally injected substances has been known to be absorbed into both sys-with intraperitoneal transplantation. Furthermore, the human UCB-derived MSCs had differentiated success-temic and portal circulations (12) . Further studies will be necessary to confirm the efficacy of intraperitoneal fully into type II pnumocytes in vitro. Moreover, a few transplanted MSCs localized and assumed the lung cell route for systemic cell administration.
Although one fourth dosage of the MSCs was given phenotypic characteristics in the in vivo damaged lung. Taken together, these findings suggest that the intratra-intratracheally than those given intraperitoneally, significantly increased numbers of donor cells were localized cheal administration of human UCB-derived MSCs might be a possible candidate for the new therapeutic modality in the intratracheal administration groups (NT and HT) than in the intperitoneal transplantation groups (NP and for the hyperoxia-induced neonatal lung diseases, such as clinical BPD.
HP) regardless of the lung injury state in this study. Furthermore, the hyperoxia-induced decrease in alveolariza-Although BM-derived MSCs and UCB-derived MSCs have a similar morphology and immuno phenotype (20) , tion was improved more prominently in HT than in HP, and the hyperoxia-induced inflammatory responses and they have distinct characteristics including different differentiation tendencies (7) and unique cytokine produc-the ensuing fibrotic reaction, such as the increased MPO activity and TNF-α, IL-6, TGF-β, α-SMA, and colla-tion properties in vitro (18, 27) . However, it is unclear if there are any in vivo differences in the various charac-gen, were also attenuated more markedly in HT than in HP. Taken together, our data suggest that the local teristics between BM-and UCB-derived MSCs. Human UCB-derived MSCs are primitive in nature and can dif-intratracheal administration of MSCs is a more effective transplantation method than the systemic intraperitoneal ferentiate into various tissues (17, 21, 25, 45) , including lung cells in vitro (4). Furthermore, human UCB-derived administration for the treatment of hyperoxia-induced neonatal lung disease. MSCs can be obtained easily and readily expanded ex vivo to a concentration sufficient for cell replacement
The protective mechanism of human UCB-derived MSCs against a hyperoxia-induced newborn lung injury therapy on account of their higher proliferation capacity compared with adult BM-derived MSCs (20, 45) . More-remains to be determined. In animal studies, the hyperoxia-induced lung injury was mediated by inflammatory over, UCB-derived MSCs can be transplanted between HLA-incompatible individuals because they barely elicit cells, such as neutrophils and macrophages (43), as well as by proinflammatory cytokines, such as TNF-α and alloreactive lymphocyte proliferate responses and modulate the immune responses (19, 23, 41) . In this study, the IL-6 (5,9,26,28,43). The hyperoxia-induced increase in mortality and the number of TUNEL-positive cells were xenotransplantation of MSCs to wild-type immunocompetent newborn rats was accomplished successfully, no observed in newborn mice overexpressing IL-6 compared with wild-type mice (9). Oritz et al. (32) reported effect was seen when the lung was normal, and beneficial effects on hyperoxic lung injury were demonstrated. that the BM-derived MSCs protected the lung tissue from bleomycin-induced lung injury by blocking TNF-Overall, these findings suggest that human UCB-derived MSCs might be a useful alternative source for MSCs-α and IL-1. In the present study, the hyperoxia-induced lung injury such as decreased alveolarization and an in-based therapies.
Although UCB-derived MSCs look similar to fibro-crease in the number of TUNEL-positive cells was accompanied by pulmonary inflammatory responses, as blasts in morphology, our in vitro data of multipotentiality could easily differentiate them from fibroblasts. Fur-evidenced by the increase in MPO activity and the levels of TNF-α and IL-6 mRNA. Human UCB-derived MSCs thermore, in our additional in vivo experiments, we have transplantation significantly attenuated the hyperoxia-damaged cells. Further studies will be necessary to clarify this. induced lung injury and the inflammatory responses. Moreover, this attenuation was more prominent in HT In conclusion, our data indicate that the intratracheal rather than the intraperitoneal transplantation of human than in HP. These findings indicate that the protective effects of MSCs therapy against a hyperoxia-induced UCB-derived MSCs significantly attenuated the hyperoxia-induced lung injury such as decreased alveolariza-lung injury are associated or mediated mainly by its antiinflammatory effects.
tion and increased fibrosis. This protective effect appears to be mediated primarily by their anti-inflammatory ef-TGF-β1 is a key fibrogenic cytokine, and activates fibroblasts differentiation into myofibroblasts (16, 37) . fects and less possibly by their differentiation into type II pneumocytes. These findings are expected to have im-The activated myofibroblasts play an important role in the process of lung fibrosis with α-SMA being an im-portant therapeutic potential for the currently untreatable hyperoxic neonatal lung disease or BPD in preterm in-portant key fibroblast myogenic marker (35). Kwong et al. (22) reported that lung inflammatory cells, such as fants. neutrophils and macrophages, are a source of TGF-β1 ACKNOWLEDGMENTS: The authors wish to thank to Dr. Su in the lung of preterm infants. Therefore, the antifibrotic 
